chr19-48639576-C-T

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001217.5(CA11):​c.613G>A​(p.Asp205Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000244 in 1,613,922 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00022 ( 1 hom., cov: 31)
Exomes 𝑓: 0.00025 ( 0 hom. )

Consequence

CA11
NM_001217.5 missense

Scores

2
9
8

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.68
Variant links:
Genes affected
CA11 (HGNC:1370): (carbonic anhydrase 11) Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes that catalyze the reversible hydration of carbon dioxide. They participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospinal fluid, saliva, and gastric acid. They show extensive diversity in tissue distribution and in their subcellular localization. CA XI is likely a secreted protein, however, radical changes at active site residues completely conserved in CA isozymes with catalytic activity, make it unlikely that it has carbonic anhydrase activity. It shares properties in common with two other acatalytic CA isoforms, CA VIII and CA X. CA XI is most abundantly expressed in brain, and may play a general role in the central nervous system. [provided by RefSeq, Jul 2008]
SEC1P (HGNC:44149): (secretory blood group 1, pseudogene) Predicted to enable galactoside 2-alpha-L-fucosyltransferase activity. Predicted to act upstream of or within protein glycosylation. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.12671995).
BS2
High AC in GnomAd4 at 33 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CA11NM_001217.5 linkc.613G>A p.Asp205Asn missense_variant 6/9 ENST00000084798.9 NP_001208.2 O75493
CA11NR_136241.2 linkn.1168G>A non_coding_transcript_exon_variant 6/9
SEC1PNR_004401.2 linkn.108+1430C>T intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CA11ENST00000084798.9 linkc.613G>A p.Asp205Asn missense_variant 6/91 NM_001217.5 ENSP00000084798.3 O75493
SEC1PENST00000474419.5 linkn.76+1430C>T intron_variant 1
SEC1PENST00000483163.1 linkn.76+1430C>T intron_variant 1
SEC1PENST00000430145.3 linkn.48+1430C>T intron_variant 2

Frequencies

GnomAD3 genomes
AF:
0.000217
AC:
33
AN:
151978
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000328
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.000957
GnomAD3 exomes
AF:
0.000298
AC:
75
AN:
251414
Hom.:
0
AF XY:
0.000265
AC XY:
36
AN XY:
135882
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000694
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000131
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000369
Gnomad OTH exome
AF:
0.000815
GnomAD4 exome
AF:
0.000247
AC:
361
AN:
1461826
Hom.:
0
Cov.:
32
AF XY:
0.000235
AC XY:
171
AN XY:
727210
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.000581
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000696
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000275
Gnomad4 OTH exome
AF:
0.000265
GnomAD4 genome
AF:
0.000217
AC:
33
AN:
152096
Hom.:
1
Cov.:
31
AF XY:
0.000215
AC XY:
16
AN XY:
74322
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.000327
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000944
Gnomad4 NFE
AF:
0.000353
Gnomad4 OTH
AF:
0.000947
Alfa
AF:
0.000208
Hom.:
0
Bravo
AF:
0.000223
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000338
AC:
41
EpiCase
AF:
0.000927
EpiControl
AF:
0.000356

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 11, 2021The c.613G>A (p.D205N) alteration is located in exon 6 (coding exon 6) of the CA11 gene. This alteration results from a G to A substitution at nucleotide position 613, causing the aspartic acid (D) at amino acid position 205 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.50
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.40
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.067
T
Eigen
Uncertain
0.53
Eigen_PC
Uncertain
0.45
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Pathogenic
0.98
D
M_CAP
Benign
0.064
D
MetaRNN
Benign
0.13
T
MetaSVM
Uncertain
-0.23
T
MutationAssessor
Benign
2.0
M
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
-2.1
N
REVEL
Uncertain
0.37
Sift
Uncertain
0.0050
D
Sift4G
Uncertain
0.024
D
Polyphen
1.0
D
Vest4
0.56
MVP
0.82
MPC
1.1
ClinPred
0.19
T
GERP RS
3.3
Varity_R
0.20
gMVP
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145539923; hg19: chr19-49142833; API